-
1
-
-
0027517659
-
The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
-
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329:1456-1462.
-
(1993)
N Engl J Med
, vol.329
, pp. 1456-1462
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
2
-
-
0028121082
-
Relationship between Ang I converting enzyme gene polymorphism, plasma levels, and diabetic complications
-
Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallar M, et al. Relationship between Ang I converting enzyme gene polymorphism, plasma levels, and diabetic complications. Diabetes 1994; 43:384-388.
-
(1994)
Diabetes
, vol.43
, pp. 384-388
-
-
Marre, M.1
Bernadet, P.2
Gallois, Y.3
Savagner, F.4
Guyene, T.T.5
Hallar, M.6
-
3
-
-
0025069003
-
The renin-angiotensin system in diabetes mellitus. A physiological and therapeutic study
-
Bjorck S. The renin-angiotensin system in diabetes mellitus. A physiological and therapeutic study. Scand J Urol Nephrol Suppl 1990; 126:1-50.
-
(1990)
Scand J Urol Nephrol Suppl
, vol.126
, pp. 1-50
-
-
Bjorck, S.1
-
4
-
-
0035922447
-
Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-860.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
-
5
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving H-H, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Amer P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870-878.
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.-H.1
Lehnert, H.2
Bröchner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Amer, P.6
-
6
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes
-
Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 2001; 345:861-869.
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
7
-
-
0030763211
-
Autonomy of the renin system in type II diabetes mellitus. Dietary sodium and renal hemodynamic responses to ACE inhibition
-
De'Oliveira JM, Price DA, Fisher NDL, Allan DR, McKnight JA, Williams GH, Hollenberg NK. Autonomy of the renin system in type II diabetes mellitus. Dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997; 52:771-777.
-
(1997)
Kidney Int
, vol.52
, pp. 771-777
-
-
De'Oliveira, J.M.1
Price, D.A.2
Fisher, N.D.L.3
Allan, D.R.4
McKnight, J.A.5
Williams, G.H.6
Hollenberg, N.K.7
-
8
-
-
0020578220
-
Endogenous Ang II as a determinant of sodium modulated changes in tissue responsiveness to Ang II in normal man
-
Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG. Endogenous Ang II as a determinant of sodium modulated changes in tissue responsiveness to Ang II in normal man. J Clin Endocrinol Metab 1983; 57:764-770.
-
(1983)
J Clin Endocrinol Metab
, vol.57
, pp. 764-770
-
-
Shoback, D.M.1
Williams, G.H.2
Hollenberg, N.K.3
Davies, R.O.4
Moore, T.J.5
Dluhy, R.G.6
-
9
-
-
0028155330
-
Endothelin-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries
-
Mori M, Akatsuka N, Fukazawa M, Hara K, Ishikawa M, Aikawa J, et al. Endothelin-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Am J Physiol 1994; 266:H583-H589.
-
(1994)
Am J Physiol
, vol.266
-
-
Mori, M.1
Akatsuka, N.2
Fukazawa, M.3
Hara, K.4
Ishikawa, M.5
Aikawa, J.6
-
10
-
-
0034211611
-
ACE inhibition and the kidney. Species variation in the mechanisms responsible for the renal haemodynamic response
-
Lansang MC, Hollenberg NK. ACE inhibition and the kidney. Species variation in the mechanisms responsible for the renal haemodynamic response. J Renin Angiotensin Aldosterone Syst 2000; 1:119-124.
-
(2000)
J Renin Angiotensin Aldosterone Syst
, vol.1
, pp. 119-124
-
-
Lansang, M.C.1
Hollenberg, N.K.2
-
11
-
-
0035066968
-
Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus
-
Lansang MC, Price DA, Laffel LMB, Osei SY, Fisher NDL, Erani D, Hollenberg NK. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int 2001; 59:1432-1438.
-
(2001)
Kidney Int
, vol.59
, pp. 1432-1438
-
-
Lansang, M.C.1
Price, D.A.2
Laffel, L.M.B.3
Osei, S.Y.4
Fisher, N.D.L.5
Erani, D.6
Hollenberg, N.K.7
-
12
-
-
0037213761
-
Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus
-
Hollenberg NK, Price DA, Fisher NDL, Lansang MC, Perkins B, Gordon MS, et al. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int 2003; 63:172-178.
-
(2003)
Kidney Int
, vol.63
, pp. 172-178
-
-
Hollenberg, N.K.1
Price, D.A.2
Fisher, N.D.L.3
Lansang, M.C.4
Perkins, B.5
Gordon, M.S.6
-
13
-
-
3042721761
-
Genes, environment, intermediate phenotypes, and the pathogenesis of diabetic nephropathy
-
Lansang MC, Hollenberg NK. Genes, environment, intermediate phenotypes, and the pathogenesis of diabetic nephropathy. Curr Pharmacogenom 2004; 2:61-74.
-
(2004)
Curr Pharmacogenom
, vol.2
, pp. 61-74
-
-
Lansang, M.C.1
Hollenberg, N.K.2
-
14
-
-
0032895814
-
Genetics of diabetic nephropathy: Evidence for major and minor gene effects
-
Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney Int 1999; 55:1582-1596.
-
(1999)
Kidney Int
, vol.55
, pp. 1582-1596
-
-
Krolewski, A.S.1
-
15
-
-
0026740639
-
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue
-
Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992; 19:339-344.
-
(1992)
Hypertension
, vol.19
, pp. 339-344
-
-
Frederich Jr., R.C.1
Kahn, B.B.2
Peach, M.J.3
Flier, J.S.4
-
16
-
-
18544397655
-
Plasma AGT concentrations in obese patients
-
Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, et al. Plasma AGT concentrations in obese patients. Am J Hypertens 1997; 10:629-633.
-
(1997)
Am J Hypertens
, vol.10
, pp. 629-633
-
-
Umemura, S.1
Nyui, N.2
Tamura, K.3
Hibi, K.4
Yamaguchi, S.5
Nakamaru, M.6
-
17
-
-
0029937834
-
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity
-
Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J, et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996; 14:199-207.
-
(1996)
J Hypertens
, vol.14
, pp. 199-207
-
-
Hopkins, P.N.1
Lifton, R.P.2
Hollenberg, N.K.3
Jeunemaitre, X.4
Hallouin, M.C.5
Skuppin, J.6
-
18
-
-
0036400374
-
Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan
-
Price DA, Lansang MC, Osei SY, Fisher NDL, Laffel LMB, Hollenberg NK. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet Med 2002; 19:858-861.
-
(2002)
Diabet Med
, vol.19
, pp. 858-861
-
-
Price, D.A.1
Lansang, M.C.2
Osei, S.Y.3
Fisher, N.D.L.4
Laffel, L.M.B.5
Hollenberg, N.K.6
-
19
-
-
31944437712
-
Body mass index and angiotensin-dependent control of the renal circulation in healthy humans
-
Ahmed SB, Fisher NDL, Stevanovic R, Hollenberg NK. Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005; 46:1316-1320.
-
(2005)
Hypertension
, vol.46
, pp. 1316-1320
-
-
Ahmed, S.B.1
Fisher, N.D.L.2
Stevanovic, R.3
Hollenberg, N.K.4
-
20
-
-
1442346948
-
-
Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Report No. ?.
-
United States Renal Disease Survey. Annual data report. Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2003. Report No. ?.
-
(2003)
Annual Data Report. Atlas of End-stage Renal Disease in the United States
-
-
-
21
-
-
0035089702
-
Renal perfusion and function in healthy African Americans
-
Price DA, Fisher NDL, Osei SY, Lansang MC, Hollenberg NK. Renal perfusion and function in healthy African Americans. Kidney Int 2001; 59:1037-1043.
-
(2001)
Kidney Int
, vol.59
, pp. 1037-1043
-
-
Price, D.A.1
Fisher, N.D.L.2
Osei, S.Y.3
Lansang, M.C.4
Hollenberg, N.K.5
-
22
-
-
0036323452
-
Renal perfusion in blacks. Alterations caused by insuppressibility of intrarenal renin with salt
-
Price DA, Fisher NDL, Lansang MC, Stevanovic R, Williams GH, Hollenberg NK. Renal perfusion in blacks. Alterations caused by insuppressibility of intrarenal renin with salt. Hypertension 2002; 40:186-189.
-
(2002)
Hypertension
, vol.40
, pp. 186-189
-
-
Price, D.A.1
Fisher, N.D.L.2
Lansang, M.C.3
Stevanovic, R.4
Williams, G.H.5
Hollenberg, N.K.6
-
23
-
-
0038579637
-
Impact of gender on renal disease. The role of the renin angiotensin system
-
Kang AK, Miller JA. Impact of gender on renal disease. The role of the renin angiotensin system. Clin Invest Med 2003; 26:38-44.
-
(2003)
Clin Invest Med
, vol.26
, pp. 38-44
-
-
Kang, A.K.1
Miller, J.A.2
-
24
-
-
0017226952
-
Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake and the renin-angiotensin system in healthy young women
-
Hollenberg NK, Williams GH, Burger BM, Chenitz WR, Hooshmand I, Adams DF. Renal blood flow and its response to angiotensin II. An interaction between oral contraceptive agents, sodium intake and the renin-angiotensin system in healthy young women. Circ Res 1976; 38:35-40.
-
(1976)
Circ Res
, vol.38
, pp. 35-40
-
-
Hollenberg, N.K.1
Williams, G.H.2
Burger, B.M.3
Chenitz, W.R.4
Hooshmand, I.5
Adams, D.F.6
-
25
-
-
23044483933
-
Oral contraceptives, angiotensin-dependent renal vasoconstriction, and the risk of diabetic nephropathy
-
Ahmed SB, Hovind P, Parving H-H, Rossing P, Price DA, Laffel LM, et al. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and the risk of diabetic nephropathy. Diabetes Care 2005; 28:1988-1994.
-
(2005)
Diabetes Care
, vol.28
, pp. 1988-1994
-
-
Ahmed, S.B.1
Hovind, P.2
Parving, H.-H.3
Rossing, P.4
Price, D.A.5
Laffel, L.M.6
-
26
-
-
0942298203
-
Treatment of the patient with diabetes mellitus and risk of nephropathy. What do we know, and what do we need to learn?
-
Hollenberg NK. Treatment of the patient with diabetes mellitus and risk of nephropathy. What do we know, and what do we need to learn? Arch Intern Med 2004; 164:125-130.
-
(2004)
Arch Intern Med
, vol.164
, pp. 125-130
-
-
Hollenberg, N.K.1
-
27
-
-
5444235005
-
Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease
-
Andersen NH, Mogensen E. Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease. Curr Hypertens Rep 2004; 6:369-376.
-
(2004)
Curr Hypertens Rep
, vol.6
, pp. 369-376
-
-
Andersen, N.H.1
Mogensen, E.2
|